SpineGuard ALSGD

PARIS, September 09, 2026--Regulatory News: SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement of bone implants, today announces its financial results for the first half of the fiscal year ended June 30, 2026, as approved by the Board of Directors held on September 9, 2026.

PARIS, August 24, 2026--Regulatory News: SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its digital surgical guidance (DSG®) technology—which measures the electrical conductivity of tissues locally in real time—to ensure the safe and simplified placement of bone implants, announced today that it has been granted a new U.S. patent by the USPTO (U.S. Patent and Trademark Office) for a robotically assisted ultrasound technology designed to determine the entry point and pedicl

PARIS & BOULDER, Colo., July 27, 2026--Regulatory News: SpineGuard (FR0011464452 - ALSGD), an innovative company specializing in Dynamic Surgical Guidance (DSG®) technology to enhance the safety and efficiency of bone implant placement, and Omnia Medical, an orthopedic implant company focused on innovative spine and sacroiliac solutions, today announced that their U.S. patent application has received notice of allowance from the USPTO (United States Patent and Trademark Office) for their innovat

PARIS & BOULDER, Colo., July 08, 2026--Regulatory News: SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement of bone implants, today announced its first half 2026 revenue.